Tarsus Pharmaceuticals Inc (TARS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -66,418 | -58,045 | -45,460 | -25,120 | -115,554 |
| Depreciation Amortization | -3,073 | -2,747 | -1,825 | -715 | -2,506 |
| Accounts receivable | -38,297 | -25,860 | -11,574 | -15,666 | -30,139 |
| Accounts payable and accrued liabilities | 6,906 | N/A | N/A | N/A | 2,544 |
| Other Working Capital | 14,638 | 1,063 | -18,265 | -1,910 | 3,844 |
| Other Operating Activity | 73,793 | 53,808 | 27,086 | 22,760 | 58,784 |
| Operating Cash Flow | $-12,451 | $-31,781 | $-50,038 | $-20,651 | $-83,027 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9,859 | -3,501 | -1,591 | -590 | -1,567 |
| Purchase Of Investment | -394,056 | -357,606 | -255,273 | -125,570 | -265,628 |
| Sale Of Investment | 361,800 | 269,718 | 170,218 | 91,218 | 73,000 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -5,000 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -5,000 |
| Investing Cash Flow | $-42,115 | $-91,389 | $-86,646 | $-34,942 | $-199,195 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 0 | N/A | 75,000 |
| Debt Repayment | N/A | N/A | 0 | N/A | -31,877 |
| Common Stock Issued | 143,388 | 141,076 | 138,514 | 136,562 | 115,056 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -3,523 |
| Financing Cash Flow | $143,388 | $141,076 | $138,514 | $136,562 | $154,656 |
| Beginning Cash Position | 97,381 | 97,381 | 97,381 | 97,381 | 224,947 |
| End Cash Position | 186,203 | 115,287 | 99,211 | 178,350 | 97,381 |
| Net Cash Flow | $88,822 | $17,906 | $1,830 | $80,969 | $-127,566 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,451 | -31,781 | -50,038 | -20,651 | -83,027 |
| Capital Expenditure | -9,859 | -3,501 | -1,591 | -590 | -1,567 |
| Free Cash Flow | -22,310 | -35,282 | -51,629 | -21,241 | -84,594 |